Egret Healthcare Ventures

What Egret Healthcare Ventures does

Egret Healthcare Ventures is a privately held, on-call venture studio headquartered in Buffalo, New York, that develops healthcare technology companies in collaboration with industry and academic partners. The studio's stated mission is to support visionary medical technology ideas, products, and companies through development to growth and strategic exit, with a focus on technologies that improve patient outcomes. It operates a portfolio of three companies: Ampullae, Inc., which develops precise tactile feedback technology for robotic surgery; Rookery Labs, Inc., an innovation incubator for medical device research and development; and Vicora, Inc., which is developing next-generation medical device catheters, including a clot-removal system that completed a GLP Pre-Clinical Study in January 2026.

The business model is equity-based: the studio generates returns through ownership stakes in its portfolio companies, with the explicit goal of positioning them for strategic exits. Revenue is therefore not product-driven but driven by capital appreciation and exit events, supplemented by any management or licensing arrangements that are not publicly disclosed. Go-to-market is relationship-led, leveraging leadership ties to regional healthcare systems (notably Catholic Health, the prior employer of CEO Marty Boryszak) and academic partners in Western New York. The studio maintains a small core team (1-10 employees) supplemented by dedicated portfolio-level operators (e.g., Shawn Patterson as CEO of Vicora and Ampullae), indicating a hub-and-spoke operating model rather than a vertically integrated device company. No patents, regulatory approvals, or named external customers are disclosed in available material.

Name

Egret Healthcare Ventures

Legal name

Egret Healthcare Ventures

Website

https://egrethealthcareventures.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Egret Healthcare Ventures is a Buffalo, NY-based venture studio that incubates and invests in early-stage medical technology companies, currently operating a portfolio of three firms focused on robotic surgery tactile feedback, medical device R&D, and next-generation clot-removal catheters, with returns driven by equity exits.

Ownership category

akta.pro rank

Product category

Healthcare Venture Studio

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Vehicles (52599)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industry

Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)

Keywords

• Healthcare venture studio
• Medical device incubation
• Healthcare technology investment
• Medical innovation funding
• Portfolio company development

Headquarters

HQ city

Buffalo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Venture Studio / Equity Investments: As a venture studio, Egret Healthcare Ventures generates returns through equity ownership in portfolio companies. The company develops healthcare technologies and companies internally, positioning them for successful growth and strategic exits.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Egret Healthcare Ventures is an on-call venture studio based in Western New York that develops and incubates cutting-edge healthcare technology companies through equity investment and hands-on development support. It operates three portfolio companies: Ampullae (precision tactile feedback for robotic surgery), Rookery Labs (medical device R&D incubator), and Vicora (next-generation medical device catheters with clot removal technology). The studio partners with industry and academic collaborators to advance portfolio companies from concept through growth stages toward strategic exits.

Product overview

Egret Healthcare Ventures is an on-call venture studio based in Buffalo, New York, that develops healthcare technologies and companies in collaboration with industry and academic partners. Rather than a single unified product, the company operates a portfolio of three distinct portfolio companies: Ampullae (precision tactile feedback systems for robotic surgery), Rookery Labs (an innovation incubator for medical device research and development), and Vicora (next-generation medical device catheters focused on clot removal technology). The venture studio supports these companies through growth phases toward successful exits.

Differentiator

Problem solved

Functional benefit

Products and services

• Ampullae A portfolio company developing technology that brings precise, tactile feedback to robotic surgery, enhancing surgeon control and precision during minimally invasive procedures. Targeted at the robotic-assisted surgery market.
• Rookery Labs An innovation incubator for medical device research and development, serving as a platform for developing new medical technologies and bringing them from concept to commercialization. Targeted at medical device inventors and early-stage developers.
• Vicora A portfolio company developing next-generation medical device catheters, with a focus on groundbreaking clot removal technology. Targeted at the vascular intervention and thrombectomy markets. The company completed a GLP pre-clinical study in January 2026 and raised $3.6 million for its catheter technology.

Quantifiable outcome

• GLP Pre-Clinical Study completed for Vicora's clot removal technology (January 2026)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Northland Workforce Training CentercoreStrategic or Co-development Partner · 1 January 2025Egret Healthcare Ventures announced a strategic partnership with Northland Workforce Training Center, indicating workforce development and training collaboration in the Western New York healthcare technology ecosystem.

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Springboard Enterprises: Accelerator and venture platform focused on healthcare, life sciences, and technology companies led by or benefiting women. Comparable as an early-stage healthcare venture platform.
• Frazier Healthcare Partners: Healthcare-dedicated growth equity and venture firm investing across medical devices, biopharma, and services. Directly comparable as a sector-focused investor developing healthcare assets through to exit.
• Longitude Capital: Healthcare-focused growth equity firm investing in medical devices, diagnostics, and life sciences. Comparable as a specialist healthcare investor backing companies through commercialization stages.
• Cedars-Sinai Health Ventures: Hospital-affiliated venture arm that incubates and invests in healthcare technologies. Directly comparable to Egret's venture studio model anchored in a health system relationship.
• Santé Ventures: Early-stage healthcare VC and venture studio that incubates and invests in medical device and digital health companies. Closely mirrors Egret's studio model.
• ARCH Venture Partners: Early-stage life sciences and medtech investor that builds companies from academic and industry partnerships. Comparable as a sector specialist originating and incubating healthcare ventures.

Emerging players

• MedTech Innovator: Medical device-focused accelerator and venture program supporting early-stage medtech companies. Comparable as an enabler of medical device commercialization pathways relevant to Egret's portfolio.
• MATTER (healthcare incubator): Chicago-based healthcare incubator supporting medical device, digital health, and biotech startups. Comparable as a healthcare-focused incubator providing development support and partner networks.

Broad incumbents

• JLABS (Johnson & Johnson Innovation): Global network of healthcare incubators run by J&J supporting early-stage medical device and pharma startups. Comparable as a healthcare incubator/venture studio though operated at much larger scale by a strategic.
• OrbiMed: One of the largest healthcare-dedicated investment firms globally across VC, growth equity, and credit. Comparable as a broad incumbent in healthcare investing, though operating at much greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/86728614/admin/dashboard

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Egret Healthcare Ventures